Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. (2024). Swiss Medical Weekly, 154(10), 3704. https://doi.org/10.57187/s.3704